SCHEMBL29017030

SCHEMBL29017030

COC(=O)c1cc(N(CC2CC2)[SH](=O)=O)ccc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 4/20 0.47
▸ CA1 P00915 4/20 0.47
▸ CA2 P00918 4/20 0.47
▸ CA7 P43166 4/20 0.47
▸ CA9 Q16790 4/20 0.47
▸ CA14 Q9ULX7 4/20 0.47
▸ PTGS2 P35354 1/20 0.40
▸ EGFR P00533 3/20 0.39
▸ NOX4 Q9NPH5 1/20 0.39
▸ TSHR P16473 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ EPHX2 P34913 1/20 0.38
▸ PDK2 Q15119 1/20 0.37
▸ PDK4 Q16654 1/20 0.37
▸ PTGER4 P35408 1/20 0.36
▸ HPGD P15428 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ GAA P10253 1/20 0.35
▸ PTPN11 Q06124 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14798684 0.80 CA12 (0.44) CA12CA1CA2CA7CA9
SCHEMBL21775704 0.73 CA12 (0.62) CA12CA1CA2CA7CA9
SCHEMBL27968758 0.71 CA12 (0.53) CA12CA1CA2CA7CA9
SCHEMBL27881584 0.67 CA12 (0.59) CA12CA1CA2CA7CA9
SCHEMBL27655420 0.66 CA12 (0.57) CA12CA1CA2CA7CA9
Methyl 2,5-Dihydroxybenzoate SCHEMBL29457577 0.65 CA12 (1.00) CA12CA1CA2CA7CA9
Methyl 2,5-Dihydroxybenzoate SCHEMBL38890 0.65 CA12 (1.00) CA12CA1CA2CA7CA9
SCHEMBL14798683 0.65 EGFR (0.45) CA12CA1CA2CA7CA9
SCHEMBL27135271 0.65 CA12 (0.51) CA12CA1CA2CA7CA9
SCHEMBL646876 0.65 CA12 (0.65) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110511173-B Indole alkyl piperazine benzamide compound and application thereof 复旦大学 2023-06-23 — — CN disclosed
Send feedback